Back to Search
Start Over
Soft Tissue Tumor with PAK2::RAF1 Kinase Fusion: An Emerging Sarcoma Entity.
- Source :
-
Case reports in oncology [Case Rep Oncol] 2024 Aug 30; Vol. 17 (1), pp. 960-965. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Introduction: Here, we report the first case of a soft tissue tumor with a PAK2::RAF1 fusion.<br />Case Presentation: The patient was an 11-year-old female presenting with a 5 cm intramuscular mass in the lower leg. Microscopic examination revealed a mitotically active spindle cell lesion with monomorphic and moderately atypical cells growing in a patternless pattern with the presence of stromal and perivascular keloidal collagen with focal immunoreactivity for smooth muscle actin and S100; negative stains included cytokeratins, CD34, and caldesmon. Whole genome and RNA sequencing detected a chromosome 3 inversion and a resultant PAK2::RAF1 fusion as well as a CDKN2A homozygous deletion. The patient was treated with neoadjuvant chemoradiotherapy with only minimal response and the tumor was excised surgically. There was no evidence of disease progression at 4 months.<br />Conclusion: This is the first case of a soft tissue tumor harboring a PAK2::RAF1 fusion with histological features in keeping with previous cases of RAF1 and other kinase fusion soft tissue tumors.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (© 2024 The Author(s). Published by S. Karger AG, Basel.)
Details
- Language :
- English
- ISSN :
- 1662-6575
- Volume :
- 17
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Case reports in oncology
- Publication Type :
- Academic Journal
- Accession number :
- 39474563
- Full Text :
- https://doi.org/10.1159/000540581